The Buongiorno CREG is the largest chronic disease management service in Europe and is being offered by a consortium of Telbios S.p.A and a collection of GPs (MMG) Co-Operatives. The purpose of the service is to manage patients with a primary diagnosis of Heart Failure, Diabetes Type I and Type II, Chronic Obstructive Pulmonary Disease (COPD), Hypertension and Ischemic Heart Disease in primary care settings or in their own homes.
The CReG Program will include a combination of services targeted at specific groups of chronically ill patients. The services will range from care co-ordination services and patient education to Tele-consultation and Telehealth. The roll-out of these services will be supported by a Telbios operated Service Center which will provide support for patients and for GP Co-Operatives who are delivering the service. The Service Center will also take responsibility for the monitoring of patients whose vital signs measurements have been captured remotely in patients' homes or GP offices and for provision of patient education and medication management services.
"We chose S3 Group as our service and solution design partner because of their deep domain expertise and specific experience in delivering a chronic disease management service. Our goal is to create specific care pathways for each chronic disease patient which can be tailored to their needs before being assigned and supervised. We are confident that S3 Group is the appropriate partner to help us achieve our goals and deliver a world-class offering that will bring huge savings and efficiencies to our health services in Italy." said Dr. Botti, CEO Telbios.
"The objective of the Buongiorno CReG Service is to create motivated and informed patients who can be treated in primary care settings or their own homes. Through our partnership with Telbios we are helping to design a service that ensures early intervention in the progression of a chronic disease and most importantly to enable the patients to take more control of their disease symptoms through education and vital sign readings. Through our work in the implementation of the Northern Ireland telemonitoring service we bring valuable experience to Telbios in the roll out of this large scale chronic disease management program in Italy and we are proud to have been chosen by them to be their partner." said Dr. Malachy Rice, Global Sales and Business Development Manager, S3 Group.
About S3 Group
S3 Group provides Telehealth consultancy services to healthcare providers, medical device vendors, primary care trusts, home healthcare agencies, accountable care organizations, and disease management companies. Our domain knowledge and experience, spanning the technological, clinical and business aspects of Telehealth, enables our clients to develop and implement robust, scalable, patient-centric holistic telehealth/telecare products and services that meet the needs of patients, their carers, clinical professionals and the wider healthcare system.
About Telbios
A pioneer in Telemedicine since 1996, Telbios has a unique case history with important public and private institutions and wide experience in the design and realization of programs and services to manage new pathways of care for the main chronic diseases and assistance of the patient at home. Telbios can count on a secure and reliable infrastructure for tele-monitoring (using terrestrial and mobile communications technologies) designed to support new ways to deliver healthcare and clinical research also through a Service Center open 24 hours a day for 365 days. Telbios has expertise in the use of medical information to create tailored, motivating directions for lifestyle improvement and health promotion. Member of Continua Health Alliance since 2007.